Clinical Trial Update: Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 Asian study completed evaluating the safety and efficacy of optimized dosing of Advagraf (Tacrolimus) for kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED